Treatment with testosterone a positive effect on the risk of prostate cancer

New scientific work has shown that patients with a reduced level of the male hormone testosterone don't need to worry about passing testosterone therapy, as the latter does not increase the risk of cancer of the prostate.

Scientists found that men who underwent treatment with the use of testosterone therapy for twelve months or more, there was no elevation in the risk of cancer of the prostate. In fact, such patients had a fifty percent lower probability of occurrence of this dangerous disease.

As stated by lead researcher Stacy Loeb, with the purpose of testosterone therapy doctors as before have to take into account such risk factors of cancer of the prostate, as the patient's age over forty years, black skin color or genetic, hereditary predisposition to this disease. However, doctors in 2016 should not be afraid to prescribe this therapy to patients for reasons of allegedly increase the risk of cancer of the prostate.